Establishment Labs Holdings Inc
Slēgts
SektorsVeselības aprūpe
83.98 2.63
Pārskats
Akcijas cenas izmaiņa
24h
Min
80.6
Max
84.72
Ienākumi | -11M -13M |
|---|---|
Pārdošana | -4.7M 60M |
EPS | -0.4 |
Peļņas marža | -22.349 |
Darbinieki | 1,004 |
EBITDA | -1.8M -6.5M |
Rekomendācijas | Pirkt (spēcīgs) |
|---|---|
Prognoze 12 mēnešiem | +8.96% upside |
Nākamie ieņēmumi | 2026. g. 6. aug. |
|---|
Tirgus kapitalizācija | 123M 2.2B |
|---|---|
Iepriekšējā atvēršanas cena | 81.35 |
Iepriekšējā slēgšanas cena | 83.98 |
Ziņu noskaņojums
By Acuity
7%
93%
3 / 342 Rangs Healthcare
Establishment Labs Holdings Inc Grafiks
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
Par Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.